Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $154,787 - $287,701
-1,224 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$225.82 - $368.51 $24,840 - $40,536
110 Added 9.87%
1,224 $311,000
Q3 2021

Nov 04, 2021

BUY
$221.9 - $484.47 $247,196 - $539,699
1,114 New
1,114 $429,000
Q4 2020

Feb 11, 2021

SELL
$65.74 - $169.86 $299,445 - $773,712
-4,555 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $247,518 - $432,041
4,555 New
4,555 $322,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $26.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Exencial Wealth Advisors, LLC Portfolio

Follow Exencial Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.